Advertisement
Organisation › Details
Ackermans & van Haaren (AvH) (Group)
Ackermans & van Haaren is a diversified group active in 5 key sectors: Marine Engineering & Infrastructure (DEME, one of the largest dredging companies in the world, and CFE and A.A. Van Laere, two construction groups with headquarters in Belgium); Private Banking (Delen Private Bank, one of the largest independent private asset managers in Belgium, asset manager JM Finn in the UK, and Bank J. Van Breda & C°, a niche bank for entrepreneurs and liberal professions in Belgium); Real Estate & Senior Care (Leasinvest Real Estate, a public regulated real estate and Extensa, an important land and real estate developer focused on Belgium, Luxembourg, and Central Europe); Energy & Resources (Sipef, an agro-industrial group working in tropical agriculture); and Development Capital (Sofinim and GIB). On the economic front, thanks to its share in its participations, the AvH Group represented a turnover of EUR 5.3 billion and employed 22,077 people. The Group concentrates on a limited number of strategic participations with significant potential for growth. AvH is quoted on the BEL20 index, the Euronext Brussels Private Equity NXT index, and the European DJ Stoxx 600. *
Start | 2016-09-01 existent | |
Industry | finance | |
Industry 2 | LIFE SCIENCES | |
Region | Antwerpen | |
Country | Belgium | |
Street | 113 Begijnenvest | |
City | 2000 Antwerpen | |
Tel | +32-3-231-8770 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | H: 10,001 to 50,00 (2016-09-01) |
Currency | EUR | |
Annual sales | 5,300,000,000 (turnover, consolidated 2015-12-31) | |
* Document for »About Section«: | ||
Record changed: 2024-02-12 |
Advertisement
More documents for Ackermans & van Haaren (AvH) (Group)
- [1] Confo Therapeutics N.V.. (7/26/24). "Press Release: Confo Therapeutics Announces EUR 60M Series B Financing to Advance a Pipeline of Novel GPCR-Modulating Therapies into Clinical Development". Ghent....
- [2] Candriam. (2/13/24). "Press Release: Candriam Strengthens Thematic Investing Expertise with New Appointments and Announces Leadership Transition". London....
- [3] Vico Therapeutics B.V.. (1/5/24). "Press Release: Vico Therapeutics Announces $60 million (€54 million) Series B Financing to Advance VO659 Clinical-Stage Program for Rare Neurological Diseases and Expand Pipeline". Leiden....
- [4] AgroSavfe N.V.. (7/30/19). "Press Release: AgroSavfe Raises €35 million in Series C Financing". Ghent....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top